JP2016527891A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016527891A5 JP2016527891A5 JP2016532782A JP2016532782A JP2016527891A5 JP 2016527891 A5 JP2016527891 A5 JP 2016527891A5 JP 2016532782 A JP2016532782 A JP 2016532782A JP 2016532782 A JP2016532782 A JP 2016532782A JP 2016527891 A5 JP2016527891 A5 JP 2016527891A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- peptide
- mutant
- seq
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361862977P | 2013-08-07 | 2013-08-07 | |
| US61/862,977 | 2013-08-07 | ||
| PCT/IB2014/063777 WO2015019318A1 (en) | 2013-08-07 | 2014-08-07 | Peptides capable of reactivating p53 mutants |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019125644A Division JP2019214573A (ja) | 2013-08-07 | 2019-07-04 | ｐ５３変異体を再活性化することの可能なペプチド |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016527891A JP2016527891A (ja) | 2016-09-15 |
| JP2016527891A5 true JP2016527891A5 (enExample) | 2017-09-14 |
| JP6554099B2 JP6554099B2 (ja) | 2019-07-31 |
Family
ID=52460737
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016532782A Expired - Fee Related JP6554099B2 (ja) | 2013-08-07 | 2014-08-07 | ｐ５３変異体を再活性化することの可能なペプチド |
| JP2019125644A Pending JP2019214573A (ja) | 2013-08-07 | 2019-07-04 | ｐ５３変異体を再活性化することの可能なペプチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019125644A Pending JP2019214573A (ja) | 2013-08-07 | 2019-07-04 | ｐ５３変異体を再活性化することの可能なペプチド |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US9856289B2 (enExample) |
| EP (1) | EP3030571B1 (enExample) |
| JP (2) | JP6554099B2 (enExample) |
| CN (1) | CN105579464B (enExample) |
| AU (2) | AU2016200713B2 (enExample) |
| BR (1) | BR112016002721A2 (enExample) |
| CA (1) | CA2920147C (enExample) |
| ES (1) | ES2795982T3 (enExample) |
| HU (1) | HUE049292T2 (enExample) |
| IL (2) | IL243944B (enExample) |
| RU (2) | RU2693487C2 (enExample) |
| WO (1) | WO2015019318A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015019318A1 (en) | 2013-08-07 | 2015-02-12 | Yeda Research And Development Co. Ltd. | Peptides capable of reactivating p53 mutants |
| CN105112377B (zh) * | 2015-09-25 | 2018-10-30 | 福州迈新生物技术开发有限公司 | 一株分泌抗p53单克隆抗体的杂交瘤细胞株及其应用 |
| CN108884137B (zh) * | 2016-02-04 | 2022-04-05 | 耶达研究及发展有限公司 | 肽及其在治疗与突变型p53相关的疾病、病症或病况中的用途 |
| US20220251159A1 (en) * | 2016-02-04 | 2022-08-11 | Yeda Research And Development Co., Ltd | Peptides and use of same in the treatment of diseases, disroders or conditions associated with a mutant p53 |
| CR20240302A (es) | 2017-09-29 | 2024-11-07 | Us Health | Receptores de células t que reconocen p53 mutado (divisional exp. 2020-0170) |
| MX2020005879A (es) | 2017-12-07 | 2020-10-07 | Reven Ip Holdco Llc | Composiciones administrables vía intravenosa que comprenden ácidos de grado farmacéutico y reguladores del ph, y el uso de las mismas para tratar enfermedades de disfunción mitocondrial, enfermedades metabólicas y de disfunción del modelado de huesos y tejidos. |
| WO2019116376A1 (en) * | 2017-12-17 | 2019-06-20 | Yeda Research And Development Co. Ltd. | Cop9 signalosome (csn) complex modulators and uses thereof |
| WO2019134070A1 (en) * | 2018-01-02 | 2019-07-11 | Rui Jin Hospital, Shanghai Jiao Tong University School Of Medicine | Panda as novel therapeutic |
| WO2019134650A1 (en) * | 2018-01-02 | 2019-07-11 | Rui Jin Hospital, Shanghai Jiao Tong University School Of Medicine | Mp53 rescue compounds and methods of treating a p53 disorder |
| PH12021553055A1 (en) * | 2019-06-12 | 2023-10-16 | Reven Ip Holdco Llc | Methods and compositions for improving outcomes of cancer patients |
| JP7402026B2 (ja) | 2019-11-27 | 2023-12-20 | 株式会社小松製作所 | 作業機械の制御システム、作業機械、作業機械の制御方法 |
| WO2021186431A1 (en) | 2020-03-16 | 2021-09-23 | Yeda Research And Development Co. Ltd. | Peptide analogs and use of same in treating diseases, disorders or conditions associated with a mutant p53 protein |
| CN111574591B (zh) * | 2020-04-29 | 2021-09-21 | 西安交通大学医学院第一附属医院 | 一种多肽及其合成方法 |
| CN113750246B (zh) * | 2020-06-04 | 2023-12-05 | 华南理工大学 | ZIF-8纳米材料在降解广谱突变p53蛋白中的应用 |
| CN111686127B (zh) * | 2020-06-04 | 2022-02-15 | 华南理工大学 | 锌铁纳米材料在降解突变p53蛋白中的应用 |
| WO2021262483A1 (en) * | 2020-06-24 | 2021-12-30 | Pmv Pharmaceuticals, Inc. | METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION |
| EP4263854A4 (en) * | 2020-12-21 | 2025-02-26 | Alaunus Biosciences, Inc. | PEPTIDASE CLEAVABLE SUBSTRATES AND METHODS OF IDENTIFICATION AND RELATED IDENTIFICATION |
| CN112921032A (zh) * | 2020-12-29 | 2021-06-08 | 苏州中科先进技术研究院有限公司 | 一种引物对、探针、试剂盒及其使用方法 |
| CN115466786A (zh) * | 2021-06-11 | 2022-12-13 | 上海交通大学医学院附属瑞金医院 | 一种筛选适合用p53复活药物治疗p53异常相关疾病病人的方法 |
| WO2026008977A1 (en) * | 2024-07-01 | 2026-01-08 | Cambridge Enterprise Limited | Protein aggregates |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5294605A (en) | 1990-07-19 | 1994-03-15 | The Scripps Research Institute | Amphiphilic peptide compositions and analogues thereof |
| US5614393A (en) * | 1991-10-10 | 1997-03-25 | Rhone-Poulenc Agrochimie | Production of γ-linolenic acid by a Δ6-desaturase |
| US5969120A (en) * | 1993-09-03 | 1999-10-19 | Research Development Foundation | Mutants of the RB and P53 genes |
| US6184205B1 (en) | 1994-07-22 | 2001-02-06 | University Of North Carolina At Chapel Hill | GRB2 SH3 binding peptides and methods of isolating and using same |
| US6169073B1 (en) * | 1995-02-16 | 2001-01-02 | Bayer Corporation | Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function |
| US5877282A (en) | 1996-09-20 | 1999-03-02 | Bristol-Myers Squibb Company | Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof |
| EP0989136A4 (en) * | 1997-05-15 | 2002-10-09 | Kyowa Hakko Kogyo Kk | PEPTIDES WITH CYCLIC STRUCTURES THAT CAN RECOVER THE ACTIVITY OF MUTED P53 PROTEINS. |
| US20030224379A1 (en) * | 2000-01-21 | 2003-12-04 | Tang Y. Tom | Novel nucleic acids and polypeptides |
| WO2002072600A2 (en) | 2001-01-26 | 2002-09-19 | Inhibitex, Inc. | Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections |
| EP1472276A4 (en) * | 2001-02-28 | 2007-05-09 | Keith M Skubitz | PEPTIDES OF SMALL SIZE CAPACITY TO MODULATE THE FUNCTION OF THE MEMBERS OF THE FAMILY OF CD66 (CEACAM) |
| US20070105778A1 (en) * | 2002-01-23 | 2007-05-10 | El-Gewely Mohamed R | Methods of screening molecular libraries and active molecules identified thereby |
| US7361747B2 (en) * | 2003-05-22 | 2008-04-22 | The University Of Hong Kong | Isolation and characterization of the precursor virus of human SARS virus: SARS-associated corona virus-like virus |
| WO2007149062A2 (en) * | 2005-03-14 | 2007-12-27 | Board Of Regents, The University Of Texas System | Bioactive fus1 peptides and nanoprticle-polypeptide complexes |
| WO2009094006A2 (en) * | 2007-10-25 | 2009-07-30 | Wake Forest University Health Sciences | Bordetella outer-membrane protein antigens and methods of making and using the same |
| EP2268658B1 (en) * | 2008-03-13 | 2015-12-09 | Universita'Degli Studi di Trieste | Peptides and aptamers thereof as specific modulators of mutant p53 function |
| US8287845B2 (en) * | 2008-12-18 | 2012-10-16 | E I Du Pont De Nemours And Company | Hair-binding peptides |
| WO2013040142A2 (en) * | 2011-09-16 | 2013-03-21 | Iogenetics, Llc | Bioinformatic processes for determination of peptide binding |
| EP3444262A3 (en) * | 2011-09-09 | 2019-04-10 | Agency For Science, Technology And Research | P53 activating peptides |
| RU2670488C2 (ru) * | 2012-09-13 | 2018-10-23 | Юниверсите Де Женев | Новые проникающие в клетку пептиды |
| WO2015019318A1 (en) | 2013-08-07 | 2015-02-12 | Yeda Research And Development Co. Ltd. | Peptides capable of reactivating p53 mutants |
| CN108884137B (zh) | 2016-02-04 | 2022-04-05 | 耶达研究及发展有限公司 | 肽及其在治疗与突变型p53相关的疾病、病症或病况中的用途 |
-
2014
- 2014-08-07 WO PCT/IB2014/063777 patent/WO2015019318A1/en not_active Ceased
- 2014-08-07 RU RU2016106583A patent/RU2693487C2/ru active
- 2014-08-07 BR BR112016002721-3A patent/BR112016002721A2/pt not_active Application Discontinuation
- 2014-08-07 HU HUE14834903A patent/HUE049292T2/hu unknown
- 2014-08-07 CN CN201480053550.8A patent/CN105579464B/zh not_active Expired - Fee Related
- 2014-08-07 RU RU2019119609A patent/RU2721423C2/ru active
- 2014-08-07 CA CA2920147A patent/CA2920147C/en active Active
- 2014-08-07 EP EP14834903.8A patent/EP3030571B1/en active Active
- 2014-08-07 JP JP2016532782A patent/JP6554099B2/ja not_active Expired - Fee Related
- 2014-08-07 ES ES14834903T patent/ES2795982T3/es active Active
-
2016
- 2016-02-04 IL IL243944A patent/IL243944B/en active IP Right Grant
- 2016-02-04 US US15/015,208 patent/US9856289B2/en not_active Expired - Fee Related
- 2016-02-04 AU AU2016200713A patent/AU2016200713B2/en not_active Ceased
-
2017
- 2017-04-28 AU AU2017202806A patent/AU2017202806B2/en not_active Ceased
- 2017-10-29 US US15/796,811 patent/US10336789B2/en active Active
-
2019
- 2019-06-25 US US16/451,081 patent/US10550152B2/en active Active
- 2019-07-04 JP JP2019125644A patent/JP2019214573A/ja active Pending
- 2019-07-30 IL IL268355A patent/IL268355A/en unknown
- 2019-12-05 US US16/704,010 patent/US11028127B2/en not_active Expired - Fee Related